📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

L718Q mutant EGFR escapes covalent inhibition by stabilizing a non-reactive conformation of the lung cancer drug osimertinib. (2018)

First Author: Callegari D
Attributed to:  Sustainable RSE Careers for Sustainable Software Development funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/c7sc04761d

PubMed Identifier: 29732058

Publication URI: http://europepmc.org/abstract/MED/29732058

Type: Journal Article/Review

Volume: 9

Parent Publication: Chemical science

Issue: 10

ISSN: 2041-6520